B+
Bull case
25%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
CPIX
CumberlandBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The Apotex consideration and retained pipeline create a potentially favorable cash-plus-optionality setup. DMD biomarker updates and multiple Phase 2 programs could support rerating if clinical or regulatory execution improves.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Clinical trial failure, inconclusive efficacy, or enrollment delays.
Momentum
97
Value
49
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.00 · Bull $9.50 · Bear $3.75Analysis 2026-09-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Why
Momentum97 · Δ7d -
Value49 · Δ7d -0.0
Sentiment68 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Clinical trial failure, inconclusive efficacy, or enrollment delays.
- • Further delay or non-availability of expected clinical data.
- • CPIX has transitioned away from its commercial portfolio into a development-stage model, so valuation depends heavily on clinical execution.
Catalyst clock
2026-08-04
Apotex transaction closed and capital returned
Lead driver: Sentiment · See AI snapshot
Momentum
97
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
49
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-8.1
Sentiment
68
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 97.0 / Value 48.6 / Sentiment 68.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$7.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$3.75
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$115.07M
Beta
-0.52
Shares Out
14.98M
P/E (TTM) · Derived
-40.2
P/S (TTM)
1.45
P/FCF (TTM)
8.97
Rev YoY
-56.3%
EPS YoY
+476.6%
Gross Margin
+72.8%
Op Margin
-29.6%
Net Debt
-$1.26M
Current Ratio
0.96
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data